Idazoxan hydrochloride
CAS No. 79944-56-2
Idazoxan hydrochloride ( —— )
产品货号. M15994 CAS No. 79944-56-2
苯并二恶烷连接的咪唑,具有 α-2 肾上腺素受体拮抗剂活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥392 | 有现货 |
|
| 10MG | ¥629 | 有现货 |
|
| 25MG | ¥1116 | 有现货 |
|
| 50MG | ¥1702 | 有现货 |
|
| 100MG | ¥2457 | 有现货 |
|
| 200MG | ¥3528 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥204 | 有现货 |
|
生物学信息
-
产品名称Idazoxan hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述苯并二恶烷连接的咪唑,具有 α-2 肾上腺素受体拮抗剂活性。
-
产品描述A benzodioxane-linked imidazole that has alpha-2 adrenoceptor antagonist activity.(In Vivo):Idazoxan (0.16-5 mg/kg; subcutaneous injection; for 1 hour; male CD-COBS rats) treatment potently reverses haloperidol-induced catalepsy with an ED50 of 0.25?mg/kg. Idazoxan (0.3 and 2.5?mg/kg) has no effect on extracellular DA and do not modify the rise of extracellular DA induced by haloperidol.
-
体外实验——
-
体内实验Idazoxan (0.16-5 mg/kg; subcutaneous injection; for 1 hour; male CD-COBS rats) treatment potently reverses haloperidol-induced catalepsy with an ED50 of 0.25?mg/kg. Idazoxan (0.3 and 2.5?mg/kg) has no effect on extracellular DA and do not modify the rise of extracellular DA induced by haloperidol. Animal Model:Male CD-COBS rats injected with 1?mg/kg haloperidol Dosage:0.16 mg/kg, 0.31 mg/kg, 0.63 mg/kg, 1.25 mg/kg, 2.5 mg/kg, and 5.0?mg/kg Administration:Subcutaneous injection; for 1 hour Result:Potently reversed haloperidol-induced catalepsy with an ED50 of 0.25?mg/kg.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点Adrenergic Receptor
-
受体Adrenergic Receptor
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number79944-56-2
-
分子量240.69
-
分子式C11H12N2O2·HCl
-
纯度>98% (HPLC)
-
溶解度Water: 100 mM
-
SMILESCl.C1CN=C(N1)C1COC2=CC=CC=C2O1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Bousquet P, et al. Ann N Y Acad Sci. 1999 Jun 21;881:272-8.
产品手册
关联产品
-
Anisodamine
Anisodamine,也称为 7β-羟基hyoscyamine,是一种抗胆碱能和 α1-肾上腺素能受体拮抗剂。
-
Nebivolol hydrochlor...
Nebivolol HydroHClide 选择性抑制 β1-肾上腺素能受体,IC50 为 0.8 nM。
-
Droxidopa
屈昔多巴是一种精神活性化合物,是神经递质去甲肾上腺素(去甲肾上腺素)和肾上腺素(肾上腺素)的前药。
021-51111890
购物车()
sales@molnova.cn

